Genetic characterization of metastasis and prognosis in high-grade serous ovarian cancer.

被引:0
|
作者
Kotnik, Emilee N. [1 ]
Spies, Nicholas C. [1 ]
Li, Tiandao [1 ]
Inkman, Matthew [1 ]
Zhang, Jin [1 ]
Martins-Rodrigues, Fernanda [1 ]
Hagemann, Ian S. [1 ]
McCourt, Carolyn K. [1 ]
Thaker, Premal H. [1 ]
Hagemann, Andrea R. [1 ]
Powell, Matthew A. [1 ]
Mutch, David G. [1 ]
Maher, Christopher A. [1 ]
Miller, Christopher A. [1 ]
Fuh, Katherine C. [1 ]
机构
[1] Washington Univ, St Louis, MO 63110 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2202
引用
收藏
页数:2
相关论文
共 50 条
  • [41] The developmental origins of high grade serous ovarian cancer.
    Lo Riso, Pietro
    Villa, Carlo Emanuele
    Gasparoni, Gilles
    Luongo, Raffaele
    Manfredi, Anna
    Vingiani, Andrea
    Jungmann, Annemarie
    Garbi, Annalisa
    Lupia, Michela
    Pruneri, Giancarlo
    Viale, Giuseppe
    Colombo, Nicoletta
    Cavallaro, Ugo
    Cacchiarelli, Davide
    Walter, Joern Erik
    Testa, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [42] (Epi)genetic Biomarkers for High-Grade Serous Ovarian Carcinoma
    Vaicekauskaite, Ieva
    Kazlauskaite, Paulina
    Gineikaite, Rugile
    Ciurliene, Ruta
    Lazutka, Juozas Rimantas
    Sabaliauskaite, Rasa
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 921 - 921
  • [43] The clinical outcome of FAP plus cancer-associated fibroblasts in high-grade serous ovarian cancer.
    Dahlstrand, Hanna
    Corvigno, Sara
    Mezheyeuski, Artur
    Carlson, Joseph W.
    Fernebro, Josefin
    Holzlwimmer, Gabriele
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Identification of Cancer Stem Cells at Single-Cell Resolution on High-Grade Serous Ovarian Cancer.
    Punzon-Jimenez, Paula
    Machado-Lopez, Alba
    Lara-Cuesta, Esther
    Lago, Victor
    Minig, Lucas
    Simon, Carlos
    Aymara, Mas
    REPRODUCTIVE SCIENCES, 2024, 31 : 153A - 154A
  • [45] Identification of lncRNA-associated ceRNA network in high-grade serous ovarian cancer metastasis
    Li, Xi
    Yu, Sihui
    Yang, Rui
    Wang, Qi
    Liu, Xiangnan
    Ma, Mingjun
    Li, Yanli
    Wu, Sufang
    EPIGENOMICS, 2020, 12 (14) : 1175 - 1191
  • [46] Clinical features of long-term survivors with advanced high-grade serous ovarian cancer.
    Barretina-Ginesta, Maria-Pilar
    Bague, Anna Carbo
    Bujons, Elisabet
    Fortian, Arola
    Fina, Claudia
    Pardo, Marta
    Melendez-Munoz, Cristina
    Cardenas, Laura
    Taltavull, Anna
    Sabate, Josep
    Darder, Esther
    Feliubadalo, Lidia
    Barretina, Jordi
    Brunet, Joan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] The tumor immune microenvironment correlates with neoadjuvant chemotherapy response in high-grade serous ovarian cancer.
    Zhu, Lei
    Cao, Guangming
    Hua, Dingchao
    Cui, Lina
    Zhao, Xiaochen
    Wang, Shuzhen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17605 - E17605
  • [48] A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer.
    Millstein, Joshua
    Budden, Timothy
    Anglesio, Michael
    Talhouk, Aline
    Beeghly-Fadiel, Alicia
    Berchuck, Andrew
    Chenevix-Trench, Georgia
    deFazio, Anna
    Fasching, Peter A.
    Gayther, Simon
    Garcia, Maria
    Goode, Ellen L.
    Henderson, Michelle
    Konecny, Gottfried E.
    Orsulic, Sandra
    Huntsman, David
    Bowtell, David
    Doherty, Jennifer
    Pharoah, Paul
    Ramus, Susan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [49] Mathematical model quantifies the effect of novel combination therapies in high-grade serous ovarian cancer.
    Hautaniemi, Sampsa
    Kozlowska, Emilia
    Farkkila, Anniina
    Vallius, Tuulia
    Carpen, Olli
    Grenman, Seija
    Lehtonen, Rainer
    Hynninen, Johanna
    Hietanen, Sakari
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 121 - 121
  • [50] Tertiary Lymphoid Structures Are Associated with a Favorable Prognosis in High-Grade Serous Ovarian Cancer Patients
    Zhang, Ke
    Xie, Xiao
    Zou, Li-Hao
    Guo, Sui-Qun
    REPRODUCTIVE SCIENCES, 2023, 30 (08) : 2468 - 2480